Virbac SA (VIRP.PA) is in Healthcare, Drug Manufacturers - General, based in France, listed on Paris. Market cap 2.67B EUR. 52-week range 297.00 to 389.50 EUR. Trailing P/E 17.1. Data as of 2026-10-09.
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection collar for dogs and cats at risk of fleas, ticks, lice, and sandflies; ...